The Catalyze Program initiatives support product development, including product definition small molecules, biologics, devices, diagnostics and enabling technologies and transformative platforms through five grant funding opportunities.
Catalyze preclinical services support preclinical development activities from end-stage proof-of-concept, through preclinical development and US regulatory approval. Applicants request specific services to advance their technology. Applications are sent to external reviewers for evaluation and if a project is selected for support, the level of support and services is negotiated between the PI and NHLBI.
Preclinical services support can include:
All applicants must submit an expression of interest form (EOI).
The recent EOI submission period ended on November 17th, 2023.
Contact us to request more information
You may download a preview of the EOI form:
Download EOI form
Selected EOI applicants will be invited to submit a full application.
Please visit the Preclinical section of our FAQ:Preclinical Services FAQ